Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.5.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Statement of Cash Flows [Abstract]    
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 1,869 $ 3,787
INVESTING ACTIVITIES    
Acquisition of business   (3,786)
Purchase of medical equipment and property (7,187) (9,474)
Proceeds from sale of medical equipment and property 1,827 1,876
NET CASH USED IN INVESTING ACTIVITIES (5,360) (11,384)
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (29,190) (43,586)
Cash proceeds from revolving credit facility 32,575 51,546
Debt issuance costs   (157)
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (33) (48)
Cash proceeds from stock plans 126 118
NET CASH PROVIDED BY FINANCING ACTIVITIES 3,478 7,873
Net change in cash and cash equivalents (13) 276
Cash and cash equivalents, beginning of period 818 515
Cash and cash equivalents, end of period $ 805 $ 791